Accuray received a Buy rating from Young Li, noting that the company benefits from Trump-era tariffs and onshoring trends.
1 report, 1 independent
Updated Jul 10
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Accuray received a Buy rating from Young Li, noting that the company benefits from Trump-era tariffs and onshoring trends.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Accuray
American radiation therapy company
-
Donald Trump
American businessman and politician (born 1946), President of the United States (2017–2021; since 2025)
Related events
- The new event concerns the impact of Trump-era tariffs and onshoring trends on Viatris.
- Elastic benefits from the trend of onshoring and tariffs associated with the Trump administration.
- Trump's tariff plan caused markets to tank, impacting Donnelley Financial Solutions.
- AI stocks are benefiting from Trump-era tariffs, and Brian Schwartz maintained an Outperform rating on Workday on September 5th.
- The Institute for Supply Management noted on August 8, 2025, that tariffs from the Trump administration were causing market volatility and hurting industry and consumers.
Coverage
Newest first; wire copies grouped- Insider MonkeyJefferies Maintains Buy Rating on Accuray Stock, Keeps PT at $4.5 Accuray Incorporated (NASDAQ:ARAY) is one of the 10 Best Small Cap Robotics Stocks to Buy Now. On June 9, Jefferies maintained a Buy